Browse the complete database of AI startup funding rounds, M&A deals, partnerships, and IPO filings from around the world.
All Time Statistics
10
Total Deals
10
Funding Rounds
0
M&A Deals
0
Partnerships
0
IPO Filings
$350M
Total Funding
| Date | Company | Event Type | Country | Sector | Key Details | Amount / Value | Round | Counterparty | Investors | Status | Article |
|---|---|---|---|---|---|---|---|---|---|---|---|
12/05/2025 | Lila Sciences | Funding | United States | Healthcare AI | $350M Series A for AI drug discovery | $350M | Series A | — | Braidwell, Collective Global | Verified | Read |
10/01/2025 | Terray Therapeutics NVDA | Funding | United States | Healthcare AI | $120M Series B with NVenture | $120M | Series B | — | ARCH Venture Partners, NVenture (Nvidia), EcoR1 Capital | Verified | Read |
08/01/2025 | Chai Discovery | Funding | United States | Healthcare AI | $70M Series A for protein structure prediction | $70M | Series A | — | Lux Capital, Obvious Ventures | Verified | Read |
02/01/2025 | Insilico Medicine | Funding | United States | Healthcare AI | $100M Series E | $100M | Series E | — | WuXi AppTec, B Capital, Qiming Venture Partners | Verified | Read |
01/15/2025 | Isomorphic Labs GOOGL | Funding | United Kingdom | Healthcare AI | $600M for AI drug discovery | $600M | Series A | — | Alphabet, Temasek, Sequoia | Verified | Read |
12/10/2024 | Abridge | Funding | United States | Healthcare AI | $150M Series C for medical transcription AI | $150M | Series C | — | Lightspeed, Redpoint, Spark Capital | Verified | Read |
04/24/2024 | Xaira Therapeutics | Funding | United States | Healthcare AI | $1B launch funding, largest in ARCH history | $1.0B | Series A | — | ARCH Venture Partners, Foresite Labs, NEA, Sequoia, Lux Capital | Verified | Read |
08/01/2023 | Recursion | Funding | United States | Healthcare AI | $100M in acquisitions | $100M | — | — | — | Verified | Read |
04/18/2023 | Genesis Therapeutics NVDA | Funding | United States | Healthcare AI | $200M Series B | $200M | Series B | — | a16z, NVentures (Nvidia), Fidelity, T. Rowe Price | Verified | Read |
01/19/2023 | Insitro | Funding | United States | Healthcare AI | $400M Series C at $2.4B valuation | $400M | Series C | — | a16z, Canada Pension Plan, ADIA, GV | Verified | Read |
$350M Series A for AI drug discovery
$120M Series B with NVenture
$70M Series A for protein structure prediction
$100M Series E
$600M for AI drug discovery
$150M Series C for medical transcription AI
$1B launch funding, largest in ARCH history
$100M in acquisitions
$200M Series B
$400M Series C at $2.4B valuation